RYR2 and type 2 diabetes mellitus: Our study in the S2814D mouse model elucidates the gain-of-function defect in RyR2 due to CaMKII hyperphosphorylation as a novel mechanism that alters insulin secretion due to β cell dysfunction, thereby contributing to the development of type 2 diabetes.